Skip to content
★ Sign in to follow
PD

Paul D'Sylva

Executive
Inhibitor Therapeutics, Inc.
Total declarations
8
Company
1
▲ Purchases (7 ops.)
€18k
▼ Sales (1 ops.)
€6,687

Latest filing published 21 Jan 2010 for Inhibitor Therapeutics, Inc., €6,687.

Insider track record

Disclosed buys
7
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Paul D'Sylva: trading record in brief

Paul D'Sylva discloses dealings in Inhibitor Therapeutics, Inc. to SEC (Form 4). In total, 8 filings cover trades dated from 30 April 2009 to 19 January 2010.

Both buying and selling appear: 7 purchases worth €18k, against 1 sale worth €6,687. Purchases outweigh sales by €11k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2010: no purchases and 1 sale on the market.

Half of the purchases are above €1,536 and half below.

Most recently, on 21 January 2010, the filings show an open-market sale worth €6,687 in Inhibitor Therapeutics, Inc. The latest purchase dates back some time: it was published 6,370 days ago, on 1 June 2009. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Paul D'Sylva

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations